Paul B. Chretien
- Oncology top 2%
- Immunology top 2%
- Surgery top 5%
- Epidemiology top 5%
- Molecular Biology
- Co-authors
- William J. CatàlonaClaude PotvinW. Frederick SampleJohn C. AlexanderA. Lee DellonJohn L. TarpleyNorman A. SilvermanAlfred S. Ketcham
- Topics
- Cancer Immunotherapy and Biomarkers (20 papers)Immunotherapy and Immune Responses (16 papers)Immune Cell Function and Interaction (12 papers)
- Partner nations
- United StatesHungarySwitzerland
In The Last Decade
Paul B. Chretien
125 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 127
- Oncology 1.3k
- Immunology 996
- Surgery 779
- Epidemiology 584
- Molecular Biology 527
Countries citing papers authored by Paul B. Chretien
This map shows the geographic impact of Paul B. Chretien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul B. Chretien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul B. Chretien more than expected).
Fields of papers citing papers by Paul B. Chretien
This network shows the impact of papers produced by Paul B. Chretien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul B. Chretien. The network helps show where Paul B. Chretien may publish in the future.
Co-authorship network of co-authors of Paul B. Chretien
This figure shows the co-authorship network connecting the top 25 collaborators of Paul B. Chretien. A scholar is included among the top collaborators of Paul B. Chretien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul B. Chretien. Paul B. Chretien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 7 | |
| 3 | 28 | |
| 4 | 1 | |
| 5 | Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adults. | 22 |
| 6 | Intracellular localization of tumor-associated antigens in murine and human malignant melanoma. | 14 |
| 7 | 24 | |
| 8 | Histologic evaluation of intraoral skin grafts and pedicle flaps in humans. | 22 |
| 9 | In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens. | 36 |
| 10 | 1 | |
| 11 | In vitro lymphocyte reactivity and T-cell levels in chronic cigarette smokers. | 71 |
| 12 | 1 | |
| 13 | 79 | |
| 14 | 51 | |
| 15 | 0 | |
| 16 | 185 | |
| 17 | 20 | |
| 18 | 4 | |
| 19 | 187 | |
| 20 | 33 |
About Paul B. Chretien
Paul B. Chretien is a scholar working on Otorhinolaryngology, Immunology and Oncology, having authored 128 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (16 papers) and Immune Cell Function and Interaction (12 papers). The work is most often cited by research in Otorhinolaryngology (368 citations), Immunology (996 citations) and Oncology (1.3k citations). Paul B. Chretien has collaborated with scholars based in United States, Hungary and Switzerland. Frequent co-authors include William J. Catàlona, Claude Potvin, W. Frederick Sample, John C. Alexander, A. Lee Dellon, John L. Tarpley, Norman A. Silverman, Alfred S. Ketcham, Peyton T. Taylor and Robert C. Hoye. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.